TOYO (TOYO) Q4 2025 earnings review
Supply Chain Pivot Triggers Massive H2 Breakout
TOYO executed a textbook supply chain pivot in 2025, and the back-half numbers show it. After a sluggish H1 bogged down by U.S. tariff dodging, the new Ethiopian cell facility reached its 4 GW capacity in October. The result? H2 revenue exploded by 641% YoY to $288.3M, pulling full-year revenue to a record $427.4M. Better yet, the shift toward higher-ASP U.S. customers pushed gross margins from 12.4% to 22.5%. While GAAP net income dipped slightly to $37.2M due to a heavy $13.7M share-based compensation charge, Adjusted Net Income surged 769% to $52.2M. With Houston module production ramping up and 2026 adjusted earnings guided to nearly double, TOYO has successfully insulated its growth engine from tariff volatility.
🐂 Bull Case
The Ethiopia facility scaling to 4 GW in Q4 was the primary catalyst for the H2 revenue surge, delivering low-cost, tariff-compliant cells for U.S. utility partners. Solar cell shipments hit 4.5 GW, beating the 4.2-4.4 GW target.
Adjusted Net Income grew 769% to $52.2M in 2025. Management's guidance of $90-$100M for 2026 implies another near-doubling of core profitability as the U.S. onshore strategy matures.
🐻 Bear Case
General & Administrative expenses nearly tripled to $31.4M, severely masking operating leverage. A $13.7M non-cash share-based compensation charge ate heavily into GAAP net income.
The earnings release completely omitted updates on the JINKO patent infringement lawsuits regarding TOPCON N-type technology, which had Markman hearings scheduled for February 2026. This overhang remains unresolved.
⚖️ Verdict: 🟢
Bullish. Management promised an agile response to U.S. tariffs, and they delivered. The H2 revenue acceleration and gross margin expansion prove the new supply chain geometry (Ethiopia + Houston) is highly profitable.
Key Themes
Ethiopian Facility Drives the Top Line
Accelerating. The strategy to bypass U.S. tariffs by building capacity in Ethiopia paid off spectacularly. The facility reached its 4 GW nameplate capacity in October 2025, pushing full-year solar cell shipments to 4.5 GW (beating the 4.2-4.4 GW guidance). For 2026, cell shipments are guided to hit 5.5-5.8 GW, indicating demand for tariff-compliant cells remains robust.
Gross Margin Transformation
Reversing. In H1 2025, gross margins compressed to 16.6% as TOYO redirected volume away from the U.S. due to tariffs. In H2, as the Ethiopian plant scaled and U.S. utility-scale deliveries resumed, full-year gross margin printed at 22.5%. This indicates H2 margins were exceptionally strong, proving that TOYO can command premium Average Selling Prices (ASPs) in the U.S. market once supply chain hurdles are cleared.
U.S. Onshoring: Houston Module Plant
Accelerating. The Houston facility delivered 249 MW of solar modules in 2025. Management expects this facility to scale rapidly, guiding for 1.0-1.3 GW of module shipments in 2026. This 'Made-in-USA' capability directly targets the U.S. utility-scale market and integrates with the VSUN brand acquisition.
Exploding Administrative Costs
Decelerating profitability on a GAAP basis. General and administrative expenses spiked 175% YoY to $31.4M. While management cites scaling the workforce and plant activations, $13.7M of this was non-cash share-based compensation. Investors need to ensure this level of dilution and executive compensation does not become a recurring feature that permanently depresses GAAP earnings.
Omitted Risk: JINKO Patent Litigation
Stable risk, but glaringly absent from current materials. In earlier quarters, TOYO disclosed a patent infringement lawsuit from JINKO over TOPCON N-type solar panel technology, with Markman hearings set for February 2026. The Q4 release makes zero mention of this existential IP risk, which could severely disrupt U.S. market access if ruled unfavorably.
Macro: Vulnerability to Trade Policy
Stable. The entire bull thesis rests on TOYO's 'traceable, tariff-compliant' supply chain. Any sudden changes to U.S. AD/CVD (Anti-Dumping and Countervailing Duties) rules targeting Ethiopian cell origins or changing domestic content requirements under the Inflation Reduction Act could force yet another costly supply chain realignment.
Other KPIs
Reversing the narrative. In H1 2025, TOYO reported a massive working capital deficit that raised 'going concern' doubts. By the end of FY25, total cash more than tripled from $17.2M at the end of 2024, driven by $132.9M in operating cash flow. The liquidity crisis appears to have been a temporary symptom of the H1 supply chain transition.
Accelerating. Up 40% from $68.2M in 2024. When excluding the $13.7M share-based compensation charge and contingent consideration changes, Adjusted EBITDA reached $110.8M (+228% YoY), proving the core cash-generating power of the new facility footprint.
Guidance
Accelerating. Implies 22-29% YoY growth over the 4.5 GW delivered in FY25. This shows confidence in the fully operational 4 GW Ethiopian facility, supplemented by other network capacity, to capture sustained U.S. utility demand.
Accelerating dramatically. Compared to just 249 MW in FY25, this implies up to 422% YoY growth. This is the ultimate test of the Houston 'Made-in-USA' facility's ability to ramp effectively without crushing margins.
Accelerating. Implies 72-91% YoY growth over FY25's $52.2M. If achieved, this validates management's claim that 2025 was a year of 'transformative execution' and heavy investment, giving way to high-margin harvesting in 2026.
Key Questions
JINKO Litigation Status
With Markman hearings previously scheduled for February 2026 regarding the JINKO patent infringement lawsuit on TOPCON N-type technology, what was the outcome, and what is the current risk to U.S. module sales?
Share-Based Compensation
Share-based compensation was a massive $13.7 million drag on GAAP earnings this year. Should investors model this as a one-time structural alignment for management, or is this the new baseline run-rate for SBC?
Houston Facility Unit Economics
As the Houston module facility scales from 249 MW to over 1 GW in 2026, what is the expected impact on blended gross margins? Will U.S. labor and operating costs dilute the high margins currently enjoyed by the Ethiopian cell production?
Onshore Cell Manufacturing
Management mentioned 'advanced planning to bring onshore cell manufacturing to the U.S.' What is the projected CapEx for this initiative, and how will it be funded given the current cash balance?